[Management of patients with higher-risk myelodysplastic syndromes]. | Rinsho Ketsueki;61(9): 1218-1226, 2020. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Search Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

[Management of patients with higher-risk myelodysplastic syndromes].

Morita, Yasuyoshi.

Affiliation

Morita Y; Division of Hematology and Rheumatology, Department of Internal Medicine, Kindai University Faculty of Medicine.

Rinsho Ketsueki ; 61(9): 1218-1226, 2020.

Article in Ja | MEDLINE | ID: mdl-33162519

Subject(s)

Hematopoietic Stem Cell Transplantation; Myelodysplastic Syndromes; Azacitidine/therapeutic use; Humans; Myelodysplastic Syndromes/therapy

Key words

Azacitidine; Hematopoietic stem cell transplantation; Myelodysplastic syndromes; Novel agents

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Hematopoietic Stem Cell Transplantation Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: Ja Journal: Rinsho Ketsueki Year: 2020 Type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Hematopoietic Stem Cell Transplantation Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: Ja Journal: Rinsho Ketsueki Year: 2020 Type: Article